0007J0.KQ Inventera Inc.

Healthcare Biotechnology KOSDAQ
7,920 KRW
Close of Oct 30, 2026
6,090 60,200
Market cap
KRW 62.3B
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is 0007J0.KQ undervalued?

Graham number

The Graham number of Inventera Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Inventera Inc. fundamental analysis

No fundamental analysis for Inventera Inc. yet.

Inventera Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Inventera Inc.

Inventera Inc. operates as a biotechnology company specializing in the development of MRI contrast agents. The company offers nanoparticle-based platforms, designed to enhance both the resolution and safety of MRI. The company develops contrast agents targeting the articular system, lymphatic vessels, and the pancreatic and biliary systems. Inventera Inc. was incorporated in 2018 and is based in Seoul, South Korea.

Full company profile